$Neumora Therapeutics (NMRA.US)$ 10% Shareholder ARCH Venture Partners XII, LLC purchased 35,010 shares of Common Stocks on Nov 13, 14, 2023 at an average price of $11.77 for a total value of $412.14K.
This transaction involves other related parties: ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT and Burow Kristina.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.